GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Days Sales Outstanding

Instituto Rosenbusch (BUE:ROSE) Days Sales Outstanding : 47.22 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch Days Sales Outstanding?

Instituto Rosenbusch's average Accounts Receivable for the three months ended in Mar. 2024 was ARS1,014 Mil. Instituto Rosenbusch's Revenue for the three months ended in Mar. 2024 was ARS1,960 Mil. Hence, Instituto Rosenbusch's Days Sales Outstanding for the three months ended in Mar. 2024 was 47.22.

The historical rank and industry rank for Instituto Rosenbusch's Days Sales Outstanding or its related term are showing as below:

BUE:ROSE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.42   Med: 129.7   Max: 194.18
Current: 48.13

During the past 13 years, Instituto Rosenbusch's highest Days Sales Outstanding was 194.18. The lowest was 44.42. And the median was 129.70.

BUE:ROSE's Days Sales Outstanding is ranked better than
74.8% of 996 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs BUE:ROSE: 48.13

Instituto Rosenbusch's Days Sales Outstanding increased from Mar. 2023 (37.62) to Mar. 2024 (47.22).

Instituto Rosenbusch Days Sales Outstanding Historical Data

The historical data trend for Instituto Rosenbusch's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch Days Sales Outstanding Chart

Instituto Rosenbusch Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 147.98 125.26 79.78 44.42 58.95

Instituto Rosenbusch Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.62 - 55.56 22.48 47.22

Competitive Comparison of Instituto Rosenbusch's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instituto Rosenbusch's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's Days Sales Outstanding falls into.


Instituto Rosenbusch Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Instituto Rosenbusch's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (757.636 + 704.991) / 2 ) / 4528.055*365
=731.3135 / 4528.055*365
=58.95

Instituto Rosenbusch's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (704.991 + 1322.994) / 2 ) / 1959.616*365 / 4
=1013.9925 / 1959.616*365 / 4
=47.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Instituto Rosenbusch  (BUE:ROSE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Instituto Rosenbusch Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Instituto Rosenbusch (BUE:ROSE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Days Sales Outstanding
Comparable Companies
BSP:ARXD11 BSP:DMVF3 BSP:SNCI11 BSP:NUTR3 BSP:JOPA3 BSP:HUCG11 BSP:DTCY3 BSP:FATN11 BSP:DVFF11 BSP:BMIN3 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Website
https://www.rosenbusch.com
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.